Differentiating celiac disease from other diseases: Difference between revisions
Line 42: | Line 42: | ||
* Signs of the fat-soluble [[Vitamin A|vitamins A]], [[Vitamin D|D]], E, and K deficiency | * Signs of the fat-soluble [[Vitamin A|vitamins A]], [[Vitamin D|D]], E, and K deficiency | ||
| | | | ||
* IgA endomysial | * [[IgA]] [[endomysial antibod]]<nowiki/>y (IgA EMA) | ||
* IgA tissue transglutaminase antibody (IgA tTG) | * IgA tissue [[transglutaminase]] antibody (IgA tTG) | ||
* IgG tissue transglutaminase antibody (IgG tTG) | * [[IgG]] tissue transglutaminase antibody (IgG tTG) | ||
* IgA deamidated gliadin peptide (IgA DGP) | * IgA deamidated [[gliadin]] [[peptide]] (IgA DGP) | ||
* IgG deamidated gliadin peptide (IgG DGP) | * IgG deamidated gliadin peptide (IgG DGP) | ||
| | | | ||
* [[Gluten-free diet]] | * [[Gluten-free diet]] | ||
| | | | ||
* HLA-DQ2 and/or DQ8 gene mutation | * HLA-DQ2 and/or DQ8 [[gene mutation]] | ||
* Innate responses to wheat proteins | * Innate responses to [[wheat proteins]] | ||
| | | | ||
* Immunoglobulin A (IgA) anti-tissue transglutaminase (TTG) antibody | * [[Immunoglobulin A]] (IgA) anti-tissue transglutaminase (TTG) antibody | ||
|- | |- | ||
|[[Lactose intolerance]] | |[[Lactose intolerance]] | ||
Line 65: | Line 65: | ||
* [[Abdominal tenderness]] | * [[Abdominal tenderness]] | ||
| | | | ||
* Stool osmotic gap of >125 mOsm/kg | * Stool [[osmotic]] gap of >125 mOsm/kg | ||
* Stool pH <6 | * Stool pH <6 | ||
| | | | ||
* Avoidance of | * Avoidance of [[Dietary|dietar]]<nowiki/>y [[lactose]] | ||
* Substitution to maintain nutrient intake | * Substitution to maintain nutrient intake | ||
* Regulation of [[calcium]] intake | * Regulation of [[calcium]] intake | ||
* Use of [[enzyme]] [[lactase]] | * Use of [[enzyme]] [[lactase]] | ||
| | | | ||
* Acquired primary lactase deficiency | * Acquired primary [[lactase deficiency]] | ||
** Adult-type hypolactasia | ** Adult-type [[hypolactasia]] | ||
** Lactase nonpersistence) | ** Lactase nonpersistence) | ||
| | | | ||
* Lactose breath hydrogen test | * [[Lactose breath hydrogen test]] | ||
|- | |- | ||
|[[Cystic fibrosis]] | |[[Cystic fibrosis]] | ||
Line 87: | Line 87: | ||
| + | | + | ||
| | | | ||
* Digital clubbing | * [[Digital clubbing]] | ||
* Respiratory rale, wheeze, and | * Respiratory [[Rales|rale]], [[wheeze]], and [[Crackles|crackle]] | ||
* Abdominal pain | * [[Abdominal pain]] | ||
* Cyanosis | * [[Cyanosis]] | ||
| | | | ||
* Positive DNA analysis for CFTR multimutation method | * Positive DNA analysis for [[CFTR]] multimutation method | ||
* Evaluated nasal transepithelial potential difference (NPD) | * Evaluated [[nasal]] [[transepithelial]] potential difference (NPD) | ||
| | | | ||
* Disease manifestations in multiple organ systems: | * Disease manifestations in multiple organ systems: | ||
** Diabetes | ** [[Diabetes]] | ||
** Recurrent upper and lower | ** Recurrent upper and lower r[[Respiratory tract infections|espiratory tract infections]] | ||
** Infertility | ** [[Infertility]] | ||
|Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein | |Mutations in the [[cystic fibrosis]] transmembrane conductance regulator (CFTR) protein | ||
| | | | ||
* Elevated sweat chloride ≥60 mmol/L | * Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | ||
|- | |- | ||
|[[Laxative abuse|Laxative overuse]] | |[[Laxative abuse|Laxative overuse]] | ||
Line 115: | Line 115: | ||
* Abdominal bloating | * Abdominal bloating | ||
| | | | ||
* | * [[Hypokalemia]] | ||
* Metabolic alkalosis | * [[Metabolic alkalosis]] | ||
* Hypermagnesemia(in case of magnesium laxative usage) | * [[Hypermagnesemia]](in case of [[magnesium]] [[laxative]] usage) | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|Laxative drug abuse | |[[Laxative]] drug abuse | ||
| | | | ||
* laxative screening on a stool for: | * [[Laxatives|laxative]] screening on a stool for: | ||
** Diphenolic laxatives (eg, | ** [[Diphenolic laxatives]] (eg, [[bisacodyl]]) | ||
** Polyethylene glycol-containing laxatives | ** [[Polyethylene glycol|Polyethylene glyco]]<nowiki/>l-containing [[laxatives]] | ||
|- | |- | ||
|[[Crohns disease|Crohns disease]] | |[[Crohns disease|Crohns disease]] | ||
Line 141: | Line 141: | ||
*[[Hypotension]] | *[[Hypotension]] | ||
| | | | ||
* [[Anemia]] | |||
* [[Iron deficiency]] | |||
* Elevated white blood cell count | |||
* Vitamin B12 deficiency | |||
* Elevated erythrocyte sedimentation rate | |||
* Elevated CRP | |||
| | | | ||
* Topical mucosamine and [[corticosteroids]] are preferred | * Topical mucosamine and [[corticosteroids]] are preferred | ||
* [[Mesalamine]] and [[sulfasalazine]] are used for remission | * [[Mesalamine]] and [[sulfasalazine]] are used for remission | ||
| | |Abnormal immune response to self antigens | ||
| | | | ||
* [[Colonoscopy]] with [[biopsy]] | * [[Colonoscopy]] with [[biopsy]] | ||
Line 262: | Line 268: | ||
| + | | + | ||
| | | | ||
* Nausea | * [[Nausea]] | ||
* Vomiting | * [[Vomiting]] | ||
* Abdominal distention | * [[Abdominal distention]] | ||
|S/E: | |S/E: | ||
* Blood-tinged and mucusy | * Blood-tinged and mucusy | ||
* Polymorphonuclear leukocytes presence | * [[Polymorphonuclear leukocytes]] presence | ||
| | | | ||
* triggered by cow's milk protein | * triggered by cow's milk protein | ||
* profuse, repetitive vomiting | * profuse, repetitive vomiting | ||
| | | | ||
|oral food challenge (OFC) | |[[oral]] food challenge (OFC) | ||
|- | |- | ||
|[[Eosinophilic gastroenteritis]] | |[[Eosinophilic gastroenteritis]] | ||
Line 282: | Line 288: | ||
| + | | + | ||
| | | | ||
* Nausea | * [[Nausea]] | ||
* Vomiting | * [[Vomiting]] | ||
* Abdominal distention | * [[Abdominal distention]] | ||
| | | | ||
* elevated serum IgE levels | * elevated [[serum]] [[IgE]] levels | ||
* abnormal D-xylose test | * abnormal D-xylose test | ||
| | | | ||
* one-half of patients have other allergic diseases | * one-half of patients have other [[allergic diseases]] | ||
* associated with an identifiable dietary antigen | * associated with an identifiable [[dietary]] [[antigen]] | ||
| | | | ||
|eosinophilic infiltration of the gastrointestinal tract on biopsy | |[[eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | ||
|- | |- | ||
|[[Microscopic colitis]] | |[[Microscopic colitis]] | ||
Line 302: | Line 308: | ||
| + | | + | ||
| | | | ||
* Abdominal tenderness | * [[Abdominal tenderness]] | ||
| | | | ||
* autoantibodies include: | * autoantibodies include: | ||
** RF | ** [[RF]] | ||
** ANA | ** [[ANA]] | ||
** AMA | ** [[Anti-mitochondrial antibody|AMA]] | ||
** ANCA | ** [[ANCA]] | ||
| | | | ||
* Fecal urgency | * Fecal urgency | ||
* Incontinence | * [[Incontinence]] | ||
* My be associated with extraintestinal symptoms, such as: | * My be associated with extraintestinal symptoms, such as: | ||
** Arthralgia | ** Arthralgia |
Revision as of 23:19, 12 September 2017
Celiac disease Microchapters |
Diagnosis |
---|
Treatment |
Medical Therapy |
Case Studies |
Differentiating celiac disease from other diseases On the Web |
American Roentgen Ray Society Images of Differentiating celiac disease from other diseases |
Differentiating celiac disease from other diseases in the news |
Risk calculators and risk factors for Differentiating celiac disease from other diseases |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Differentiating Celiac Disease from Other Diseases
The table below summarizes the findings that differentiate causes of chronic diarrhea[1][2][3][4][5][6][7]
Cause | Diarrhea | Age of onset | History | Physical exam | Lab findings | Additional finding | Cause | Gold standard dignosis | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Watery | Fatty | Weight loss | FTT | Abdominal pain | |||||||
Celiac disease | +/- | +/- | Childhood
Adult |
+ | + | + |
|
|
|
| |
Lactose intolerance | + | - | Adult | - | - | + |
|
|
|||
Cystic fibrosis | - | + | Infancy and childhood | + | + | + |
|
|
|
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein |
|
Laxative overuse | + | - | After childhood | +/- | - | +/- |
|
|
- | Laxative drug abuse |
|
Crohns disease | + | - | Young adults
(20th) |
+ | + |
|
|
|
Abnormal immune response to self antigens |
| |
Hyperthyroidism | + | - |
|
|
|||||||
VIPoma | + | - | + |
|
|
| |||||
Irritable bowel syndrome | + | - |
|
|
| ||||||
lactose intolerance | - | + |
|
|
Lactose breath hydrogen test | ||||||
Whipple disease | - | + | + | - | + |
|
Upper endoscopy with biopsies of the small intestine for T. whipplei testing (histology with PAS staining, polymerase chain reaction [[[PCR]]] testing, and immunohistochemistry) | ||||
Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | + | - | Infancy | +/- | +/- | + | S/E:
|
|
oral food challenge (OFC) | ||
Eosinophilic gastroenteritis | + | - | 3rd decade | +/- | +/- | + |
|
eosinophilic infiltration of the gastrointestinal tract on biopsy | |||
Microscopic colitis | + | - | 6th decde | + | - | + |
|
| |||
Congenital chloride diarrhea | + | - | Neonate | + | + | - | - |
|
|
| |
Congenital sodium diarrhea | + | - | Neonate | + | + | - | - | S/E:
Serum:
|
|
||
Glucose-galactose malabsorption | + | - | Infancy | + | +/- | + | Abdominal tenderness |
|
| ||
Abetalipoproteinemia | - | + | Infancy | + | + | + | Abdominal distention
Impaired visual acuity and visual field defects Dysarthria |
Low triglyceride
Low total cholesterol levels Acanthocytes Low vitamin E levels |
Clumsiness
vision impairment Ataxia |
|
Clinical findings and low triglyceride and cholesterol level |
Primary bile acid malabsorption | + | +/- | Childhood Adolescents | + | + | +/- | - | Disease hetergenicity lead to varying presentation from chronic diarrhea without significant fat malabsorption to severe watery diarrhea and steatorrhea with malnutrition |
|
| |
Cause | Diarrhea | Age of onset | History | Physical exam | Lab findings | Additional finding | Cause | Gold standard dignosis | |||
Watery | Fatty | Weight loss | FTT | Abdominal pain | |||||||
Gastrinoma (Zollinger-Ellison syndrome) | + | - | between the ages of 20 and 50 | + | +/- | + | Mild to moderate upper abdominal tenderness | Positive secretin stimulation test
Elevated serum chromogranin A |
heartburn | Gastrin producing tumor mainly in duodenum | elevated basal or stimulated serum gastrin more than 1000 pg/mL |
(solute-linked carrier famly 26 member A3)
oral food challenge (OFC):
References
- ↑ Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
- ↑ Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
- ↑ Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.
- ↑ RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.
- ↑ Hertzler SR, Savaiano DA (1996). "Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance". Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
- ↑ Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). "Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?". Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
- ↑ BLACK-SCHAFFER B (1949). "The tinctoral demonstration of a glycoprotein in Whipple's disease". Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.